PHARMALDEIA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMALDEIA
Largest movements
- Deferred charges and accrued income -€16,731
down €16,731 (-17.7%), from €94,452 to €77,721
- Stocks and contracts +€8,096
up €8,096 (+10.1%), from €79,929 to €88,025
- Reserves +€38,812
up €38,812 (+13.2%), from €293,279 to €332,090
of which Distributable reserves: +€38,812
- Other debts -€31,906
down €31,906 (-28.9%), from €110,424 to €78,518
- Debts after one year -€16,500
down €16,500 (-26.7%), from €61,875 to €45,375
- Gross operating margin +€16,127
up €16,127 (+11.4%), from €141,918 to €158,045
- Taxes +€5,167
up €5,167 (+25.5%), from €20,255 to €25,422
- Financial charges -€4,134
down €4,134 (-28.5%), from €14,527 to €10,393
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €698,125 | €683,646 | -€14,479 | -2.1% |
| Fixed assets | 21/28 | €275,207 | €270,640 | -€4,566 | -1.7% |
| Tangible fixed assets | 22/27 | €275,207 | €270,640 | -€4,566 | -1.7% |
| Land and buildings | 22 | €223,310 | €231,448 | +€8,137 | +3.6% |
| Plant, machinery and equipment | 23 | €2,566 | €1,877 | -€689 | -26.8% |
| Furniture and vehicles | 24 | €49,330 | €37,316 | -€12,015 | -24.4% |
| Current assets | 29/58 | €422,918 | €413,006 | -€9,912 | -2.3% |
| Stocks and contracts in progress | 3 | €79,929 | €88,025 | +€8,096 | +10.1% |
| Stocks | 30/36 | €79,929 | €88,025 | +€8,096 | +10.1% |
| Amounts receivable within one year | 40/41 | €2,783 | €901 | -€1,882 | -67.6% |
| Trade receivables | 40 | €2,265 | €425 | -€1,840 | -81.2% |
| Other amounts receivable | 41 | €517 | €476 | -€41 | -8.0% |
| Cash at bank and in hand | 54/58 | €245,754 | €246,359 | +€604 | +0.2% |
| Deferred charges and accrued income | 490/1 | €94,452 | €77,721 | -€16,731 | -17.7% |
| Total equity and liabilities | 10/49 | €698,125 | €683,646 | -€14,479 | -2.1% |
| Equity | 10/15 | €343,279 | €382,090 | +€38,812 | +11.3% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €293,279 | €332,090 | +€38,812 | +13.2% |
| Tax-exempt reserves | 132 | €16,650 | €16,650 | = | 0.0% |
| Distributable reserves | 133 | €276,629 | €315,440 | +€38,812 | +14.0% |
| Amounts payable | 17/49 | €354,846 | €301,556 | -€53,290 | -15.0% |
| Amounts payable after more than one year | 17 | €61,875 | €45,375 | -€16,500 | -26.7% |
| Financial debts | 170/4 | €61,875 | €45,375 | -€16,500 | -26.7% |
| Amounts payable within one year | 42/48 | €279,628 | €244,308 | -€35,320 | -12.6% |
| Current portion of amounts payable after more than one year | 42 | €16,500 | €16,500 | = | 0.0% |
| Trade debts | 44 | €133,634 | €131,902 | -€1,732 | -1.3% |
| Suppliers | 440/4 | €133,634 | €131,902 | -€1,732 | -1.3% |
| Taxes, remuneration and social security | 45 | €19,070 | €17,387 | -€1,682 | -8.8% |
| Taxes | 450/3 | €19,070 | €17,387 | -€1,682 | -8.8% |
| Other amounts payable | 47/48 | €110,424 | €78,518 | -€31,906 | -28.9% |
| Accrued charges and deferred income | 492/3 | €13,344 | €11,874 | -€1,470 | -11.0% |
| Non-recurring operating income | 76A | €4,000 | - | -€4,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €43,992 | €45,018 | +€1,026 | +2.3% |
| Other operating charges | 640/8 | €14,607 | €14,611 | +€4 | 0.0% |
| Gross operating margin | 9900 | €141,918 | €158,045 | +€16,127 | +11.4% |
| Operating profit (loss) | 9901 | €83,319 | €98,416 | +€15,097 | +18.1% |
| Financial income | 75/76B | €1,528 | €1,952 | +€424 | +27.7% |
| Recurring financial income | 75 | €1,528 | €1,952 | +€424 | +27.7% |
| Financial charges | 65/66B | €14,527 | €10,393 | -€4,134 | -28.5% |
| Recurring financial charges | 65 | €14,527 | €10,393 | -€4,134 | -28.5% |
| Profit (loss) for the period before taxes | 9903 | €70,321 | €89,976 | +€19,655 | +28.0% |
| Income taxes | 67/77 | €20,255 | €25,422 | +€5,167 | +25.5% |
| Profit (loss) for the period | 9904 | €50,066 | €64,554 | +€14,488 | +28.9% |
| Profit (loss) for the period to be appropriated | 9905 | €50,066 | €64,554 | +€14,488 | +28.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.